Chemoinformaics analysis of heptadeca-1-cis-8-cis-15-triene-11,13-diyne
| Molecular Weight | 226.363 | nRot | 7 |
| Heavy Atom Molecular Weight | 204.187 | nRig | 5 |
| Exact Molecular Weight | 226.172 | nRing | 0 |
| Solubility: LogS | -6.287 | nHRing | 0 |
| Solubility: LogP | 5.748 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 43.0594 |
| nHD | 0 | BPOL | 22.0706 |
| QED | 0.337 |
| Synth | 3.575 |
| Natural Product Likeliness | 3.016 |
| NR-PPAR-gamma | 0.017 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.008 |
| CACO-2 | -4.2 |
| MDCK | 0.0000616 |
| BBB | 0.002 |
| PPB | 1.0219 |
| VDSS | 2.031 |
| FU | 0.0100739 |
| CYP1A2-inh | 0.973 |
| CYP1A2-sub | 0.414 |
| CYP2c19-inh | 0.927 |
| CYP2c19-sub | 0.422 |
| CYP2c9-inh | 0.89 |
| CYP2c9-sub | 0.959 |
| CYP2d6-inh | 0.886 |
| CYP2d6-sub | 0.382 |
| CYP3a4-inh | 0.931 |
| CYP3a4-sub | 0.185 |
| CL | 4.898 |
| T12 | 0.261 |
| hERG | 0.002 |
| Ames | 0.273 |
| ROA | 0.024 |
| SkinSen | 0.973 |
| Carcinogencity | 0.714 |
| EI | 0.991 |
| Respiratory | 0.465 |
| NR-Aromatase | 0.854 |
| Antiviral | Yes |
| Prediction | 0.774749 |